Declining immune responsiveness with age may be driven by changes in immune cells — not by inflammation, as previously ...

Regulatory mechanisms governing stem cell quiescence in glandular organs remain ill-defined. Here, multi-omics profiling ...

Qiagen has identified Parse Biosciences’ technology as complementary to its sample technology and bioinformatic businesses.

With the introduction of ONT-based plasmid sequencing, Novogene further strengthens its position as a trusted hub for advanced sequencing solutions, expanding its capabilities in both long- and ...

Integrates Alithea Genomics’ MERCURIUS FLASH-seq single-cell RNA-seq protocol with SPT Labtech’s firefly liquid handling ...

The acquisition, which enables Qiagen to enter the single-cell sequencing market, is expected to close in December and contribute $40 million to 2026 revenues.

QIAGEN today announced it has entered into a definitive agreement to fully acquire Parse Biosciences, a leading provider of scalable, instrument-free solutions for single-cell research. The ...

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first ...

A new AI model called Nicheformer restores spatial context to single-cell data, showing how cells organize within tissues.

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first ...

Missing Context in Single-Cell DataSingle-cell RNA sequencing has transformed biology by showing which genes are active in individual cells. However ...

Immunotherapy with immune checkpoint inhibitors is standard first-line treatment for advanced renal cell carcinoma (RCC), but ...